A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
|
|
- Gladys Harper
- 5 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (1991) 28, Suppl. C, A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe F. Baqoero*, J. Martfnez-Beltran and E. Loza Servicio de Microbiologla, Hospital Ramdn y Cajal, Institute National de la Salud, 2834 Madrid, Spain Streptococcus pneumoniae no longer has predictable antibiotic susceptibility. There are two areas of high prevalence of resistance (over 25%) to /J-lactam antibiotics in the South-West and North-East of Europe. In Spain, a close relationship has been found between the yearly rate of aminopenicillin consumption and penicillin resistance. High level resistance (MIC ^ 1 mg/l) has developed against a previous background of low level resistance. The serotypes involved in penicillin resistance in Spain are widespread in other countries. Macrolide resistance is high in France (over 15%) and is also increasing in other countries. All these resistant isolates remain susceptible to the most recent fluoroquinolones, such as tcmafloxacin. Prospective surveillance, more rational use of antibiotics and a diversification of antibiotic use in respiratory tract infections may serve to limit the threat of antibiotic resistance in 5. pneumoniae. Introduction Streptococcus pneumoniae remains a common bacterial pathogen in human infections. Antibiotic use in Europe has commonly been targetted against streptococcal infections, particularly those of the respiratory tract in children, young adults and the elderly. The enormous empirical use of penicillins in community practice over the last quarter of a century has frequently been based on the wide acceptability and tolerance of these drugs, and the belief that the treatment of streptococcal infections was not limited by antibiotic resistance. Unfortunately, this has clearly been an underestimate of the adaptational and evolutional capabilities of the genus Streptococcus. Microbiologjsts, although concerned for years by plasmid mediated resistance in Gram-negative bacteria, have only realized during the last decade that streptococci may be equally resistant to antibiotics. Downloaded from at Pennsylvania State University on April 8, 216 Distribution of penicillin-resistance of S. pneumoniae in Europe From information available in the literature an estimate of the current distribution of penicillin resistance in European countries is shown in Figure 1. Spain, as well as Poland and Hungary are the main centre 5 of resistance, with more than a third of the isolates with MICs > 1 mg/l; the United Kingdom has a low prevalence of resistance, under 4% (Ridgway & Allen, 1991). Most other European countries have overall Correspondence to: Dr F. Baquero /91/28C31 +8 $2./ The British Society for Antimicrobial Chemotherapy
2 32 F. Baqnero et al Spain Hungary Poland Belgium Italy France U.K. Swtz. Germany Figure 1. S. pneumoniar. penicillin resistance in Europe (1986/1989). resistance rates < 9%. Nevertheless, local pockets of resistance (over 1%) have been recently communicated to us by microbiologists from France and the United Kingdom. Penicillin resistance world-wide has recently been reviewed (Klugman, 199). Evolution of peniefflin-resistant S. pneumoniae isolates in Spain: a predictive model for Europe? In 1973, our group in Madrid recorded 3% of S. pneumoniae with reduced susceptibility to penicillin. The development of resistance can be traced from the data obtained Downloaded from at Pennsylvania State University on April 8, Flgare 2. The incidence of penicillin resistance among strains of S. pneumoniae causing systemic infections (2197 strains)., MIC mg/l; O. MIC > 2mg/L.
3 Pneamococcal resistance Europe Unrtt (xl,o,o/yeor) Figure pmumoniae resistance to penicillin by penicillin usage in a continuous survey of penicillin susceptibility among clinical isolates of S.pneumoniae during the last decade in the Central Laboratory for Sanitary Microbiology, Madrid (Fenoll & Casal, 199; Fenoll et al., 1991) (Figure 2). Low-level resistance (MIC mg/l) increased"" 51 " with a high level of antibiotic resistance (MIC > 1 mg/l) appearing in 1984, and rising to nearly 17% in 199. Antibiotic use and S. pneumoniae resistance There is a very clear relationship between the annual aminopenicillin consumption and the rate of penicillin resistance in S. pneumoniae in Spain over the past decade (Figure 3), with a similar significant correlation between resistance rates and the use of aminopenicillins in community acquired respiratory tract infections (Baquero et al., 199). This correlation was present in each of the Spanish regions analysed: in Northern Spain and Valencia antibiotics are used in less than 2% of the patients who attend out-patient clinics for respiratory tract infections, and here less than 15% of pneumococci are resistant. On the contrary, antibiotics are prescribed for more than 3% of patients in Aragon, Catalonia and Madrid, and here the rate of penicillin resistance is over 3%. There is a relationship between the overall consumption of aminopenicillins and the emergence and spread of penicillin-resistant S.pneumoniae was a very significant year for the evolution of penicillin resistance in Spain (see Figure 2); 27 million units were prescribed in comparison to 18 in France, 16 in Italy and 5 million in the United Kingdom. Downloaded from at Pennsylvania State University on April 8, 216
4 34 F. Bsqnero et al -1 I II Figure 4. Serotypes of S. pneumoniae and penicillin susceptibility: the higher limit in MIC range is represented for each icrotype. Epidemiology of penicillin-resistant S. pneumoniae Serotyping of 5. pneumoniae (Fenoll & Casal, 199; Fenoll et al., 1991) isolates during the last decade in Spain has revealed some important epidemiological features. Serotypes presenting resistance to penicillin are the common serotypes to be found in the population. This indicates that selective antibiotic pressure is exerted among endemic strains. Isolates showing a higher level of penicillin resistance belong predominantly to the more frequent serotypes 6, 9, 14, 15, 19 and 23 (Figure 4). The same serotypes are also frequently associated with antibiotic resistance in other European countries, such as France (serotypes 6, 14, 15, 19,23; Acar & Buu-Hoi, 1988), Belgium (serotypes 6, 9, 14, 15, 19, 23; Verhaegen et al., 199), Germany (serotypes 6, 14, 19) and Russia (scrotype 19) (Katosova et al., 199). However, some common serotypes present a very low rate of penicillin resistance. This may be due to a specific susceptibility to acquire resistance in some strains. Nevertheless, as shown in Figure 4, almost all serotypes can acquire penicillin resistance. Downloaded from at Pennsylvania State University on April 8, 216 The natural history of penicillin resistant S. pneumoniae The evolution and spread of penicillin resistant S. pneumoniae appears to closely parallel the use of /Mactam drugs. One hypothesis for this development of resistance suggests a progressive reduction of highly susceptible strains. This is followed by a change in the respiratory tract flora to streptococci with tolerance or low level penicillin resistance. The modified PBP2b of S. pneumoniae (conferring high level penicillin resistance) is the consequence of a long process involving the mutational alteration of 74 nucleotides thereby changing at least 17 aminoacids in the transpeptidase area of the PBP (Dowson et al., 1989, 199). During this molecular evolution of the enzyme, a wide range of 'low resistance' phenotypes may appear.
5 Pnenmococcalresistance Europe 35 Natural selection will produce an increase among some low level resistant strains which in turn may colonize not only patients but the normal population. The selective effect of antibiotic consumption in populations colonized by low-level resistance strains will gradually encourage the emergence of high-level resistance variants. This process will be accelerated by genetic transformation. Pieces of DNA encoding altered PBPs are exchanged between streptococci leading to a highly complex genetic polymorphism among such organisms (Jabes, Nachman & Tomasz, 1989; Markiewicz & Tomasz, 1989; Tomasz et al., 1989; Dowson et al., 199). If the streptococci with high level resistance are not successfully treated, dissemination may occur independently of antibiotic usage. There may be modulation of the colonizing ability of resistant strains by the phenomenon of 'herd immunity' among the human population. Eventually, this may disadvantage resistant streptococci, leading to a resurgence of more susceptible strains. This may also be the consequence of changes in the PBP of resistant strains, so that the enzymes become altered for their reactivity toward natural substrates. That may cause ecological disadvantages, unless the strains acquire auxiliary mutations that assure a sufficient supply of cell wall precursors (Jabes, et al., 1989). These changes could eventually be incorporated into the chromosome. There has been an unexpected high rate of penicillin resistance among the viridans streptococci group. Nearly 5% of such isolates from blood cultures during the last three years showed increased MICs of penicillin, particularly in S. sanguis, S. mitis S. salivarius and 5. mutans (Loza et al., 199). The evolution of macrolide resistance in S. pneumonia* As with penicillin resistance, macrolide resistance among S. pneumoniae tends to correlate with the consumption of these drugs. This is highest in France, where the rates were around 6% in the 197s and exceeded 25% in The rate of macrolide consumption outside hospitals is also higher in France than in other European countries (12-5 million units in 1983, compared with 8 million in Spain or 2-3 million in Germany or in the United Kingdom). As in the rest of Europe, the rate of erythromycin resistance in Spain was under 4% in Two years later, the rate had doubled (8-4% in 1987), and reflects the significant increase in consumption (8-6 million of units in 1984 and 11-8 million in 1987). A similar increase seems to have occurred in Belgium, where resistant rates increased from nearly 3% in 1983 to 12% in 1988 (Verhaegen et al., 199). Downloaded from at Pennsylvania State University on April 8, 216 The evolution of cmorampbenkol and tetracycline resistance In Spain, chloramphenicol consumption decreased from 2 million of units in 1976 to less than -5 million in 1985, with a decrease in chloramphenicol resistance from 7% in 1976 to 36% in The same trend was seen with tetracyclines: the reduction in consumption (from 2 million in 1976 to nearly 5 million in 1988), parallels the reduction in resistance (77% in 1979 and 42% in 1988). Some resistance is maintained despite lower use from the selective pressure of the aminopenicillins, due to the frequent association of resistance mechanisms in the same organism (particularly frequent in serotype 23).
6 36 F. Baquero et al Table. Susceptibility of S. pneumoniae and viridans streptococci to temafloxacin Percentage of strains inhibited at each concentration (mg/l) " S. pneumoniae Pen-S (13) Pen-I(116) Pen-R(117) viridans streptococci Pen-S (39) Pen-I (23) Pen-R (1) Pen S, I, R., Susceptible, intermediate or resistant to penicillin Antibiotic resistance in S. pneumoniae. the role of fluoroquinolones The recent development of fluoroquinolones with increased activity for Gram-positive organisms represents a new possibility for the treatment of resistant S. pneumoniae infections. The good activity of temafloxacin for S. pneumoniae isolates has recently been reported (Mazzuli et al., 199; Swanson et al., 1991). The susceptibility of Spanish isolates of S. pneumoniae and viridans streptococci to temafloxacin is presented in the Table. Penicillin resistance does not influence significantly the MIC of temafloxacin for 5. pneumoniae; both penicillin susceptible and resistant isolates are inhibited by 1 mg/l although penicillin susceptible streptococci exhibit a slightly lower MIC. PBP modifications may affect cell wall growth, which can modulate the DNA replicative or transcriptional mechanisms, where quinolones act. The bronchial mucosal concentrations of temafloxacin will exceed those required to inhibit most penicillin resistant streptococci (Baldwin etal., 199; Swanson et al., 1991). However, the widespread use of fluoroquinolones with low activity for Gram-positive organisms may contribute to the development of resistance to this family of antibiotics. Selection of quinolone resistant variants of S. pneumoniae, associated with therapeutic failure, may occur during treatment of pneumonia with ciprofloxacin (Perez-Trallero et al., 199). New quinolones with improved efficacy could be used for pneumococcal infections Downloaded from at Pennsylvania State University on April 8, 216 The future: what to do? Continuous monitoring of streptococcal susceptibility should be carried out. When predicting antibiotic resistance, S. pneumoniae and the Enterobacteriaceae have similarities. Regular surveillance of resistance in normal flora, particularly in school children and the elderly should be done, with an exchange of data obtained in different countries. The use of antibiotics in the community should be limited as far as possible. The indications for antibiotic therapy in respiratory tract infections should bereviewed.the use of pneumococcal vaccines may diminish the need for antibiotics but is unsubstantiated.
7 Pneumococcal resistance Europe 37 Treatment of patients carrying penicillin resistant S. pnewnoniae (even as commensal flora) with any /J-lactam drug can contribute to the spread and evolution of resistance. Even viral respiratory tract infections contribute to the spread of resistant organisms. Diversification in the use of antimicrobials used to treat respiratory tract infections will reduce the selective pressure. Part of this strategy may include the use of macrolides, or new Gram-positive active fluoroquinolones, such as temafloxacin. The widespread use of quinoloncs with low activity for Gram-positive organisms and/or very low concentrations in respiratory secretions should be discouraged. In summary, better selection of patients for treatment is necessary, particularly in respiratory tract infections of the community. There should also be better selection of the antimicrobial agents, considering the danger of spread of resistant pathogenic organisms. New antimicrobials, like temafloxacin, may help to implement this strategy. Acknowledgements To A. Fenoll, J. Casal, J. Acar, J. A. Saez-Nieto, I. Phillips, J. Lifiares, J. Campos, A. Tomasz and R. Lopez, for providing data, constructive criticism and discussion. References Acar, J. F. & Buu-Hoi, A. Y. (1988). Resistance patterns of important Gram-positive pathogens. Journal of Antimicrobial Chemotherapy 21, Suppl. C, Baldwin, D. R., Wilkinson, L., Andrews, J. M., Ashby, J. P., Wise, R. & Honeybourne, D. (199). Concentrations of temafloxacin in serum and bronchial mucosa. European Journal of Clinical Microbiology and Infectious Diseases 9, Baquero, F., Bernal, B., Garau, X. & Gobernado, M. (Eds) (199). E.N.I.R.:Estudio Nacional de la Infeccidn Respiratoria, SOCIMED, Madrid. Dowson C. G., Hutchison, A., Brannigan, J. A., George, R. C, Hansman, D., Linares, J. et al. (1989). Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proceedings of the National Academy of Sciences USA 86, Dowson, C. G., Hutchison, A., Woodford, N., Johnson, A. P., George, R. C. & Spratt, B. G. (199) Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proceedings of the National Academy of Sciences USA 87, Fenoll Comes, A. & Casal Lombos, J. (199). Origen y bases moleculares de la resistencia a penicilina en S. pneumoniae. Revista EspaRola de Quimioterapia 3, Fenoll, A., Martin Bourgon, C, Munoz, R., Vicioso, D. & Casal, J. (1991). Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, Reviews of Infectious Diseases 13, Jabes, D., Nachman S. & Tomasz, A. (1989). Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. Journal of Infectious Diseases 159, Katosova, L. K., Sidorina, T. M., Baturo, A. P. & Sotnikova, G.D. (198) Serotypes of pneumococci in children with chronic inflammatory diseases on respiratory organs. Microbiology, Epidemiology and Immunobiology 2, Klugman, K. P. (199). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, Loza, E., Martinez-Beltran J., Elia, M., Almaraz, F., Negri, C, Morosini, M. I. et al. (199). High incidence of penicillin resistance in viridans streptococci blood isolates: their susceptibility patterns. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy. Atlanta, 199, Abstract 694. American Society for Microbiology, Washington, DC. Downloaded from at Pennsylvania State University on April 8, 216
8 38 F- Baquero et al Markiewicz, Z. & Tomasz, A. (1989). Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. Journal of Clinical Microbiology 27, Mazzuli, T., Simor, A. E., Jaeger, R., Fuller, S. & Low, D. E. (199). Comparative in vitro activity of several new fluoroquinolones and -lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 34, Perez-Trallero, E., Garcia-Arenzana, J. M. Jimenez, J. A. & Peris, A. (199). Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 9, Ridgway, E. J. & Allen, K. D. (1991). Penicillin resistance in pneumococci. Journal of Antimicrobial Chemotherapy 27, Swanson, R. N., Hardy, D. J., Chu, D. T. W., Shipkowitz, N. L. & Clement, J. C. (1991). Activity of temafloxacin against respiratory pathogens. Antimicrobial Agents and Chemotherapy 35, Tomasz, A., Jabes, D., Markiewicz, Z., Garcia-Bustos, J. & Nachman, S. (1989) Multiple penicillin binding protein profiles in penicillin resistant pneumococci: evidence for the clonal nature of resistance among clinical isolates. Current Topics in Infectious Diseases and Clinical Microbiology 2, 11-2 Verhaegen, J., Glupczynslci, Y., Verbist L., Blogie, M., Vandeven, J., Yourassowsky, E. et al. (199). Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 198 to European Journal of Clinical Microbiology and Infectious Diseases 9, Downloaded from at Pennsylvania State University on April 8, 216
Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationModeling the Emergence of Multidrug Antibiotic Resistance
ISDC 2001 - Atlanta, USA Modeling the Emergence of Multidrug Antibiotic Resistance Jack Homer, Ph.D Homer Consulting James Jorgensen, Ph.D Prof. of Pathology & Medicine Univ. of Texas, San Antonio Kate
More informationAntimicrobial resistance: a class effect?
Journal of Antimicrobial Chemotherapy (2002) 50, Suppl. S2, 7 12 DOI: 10.1093/jac/dkf508 Antimicrobial resistance: a class effect? J. Prieto*, A. Calvo and M. L. Gómez-Lus Microbiology I Department, School
More informationAntimicrobial Resistance and Prescribing
Antimicrobial Resistance and Prescribing John Ferguson, Microbiology & Infectious Diseases, John Hunter Hospital, University of Newcastle, NSW, Australia M Med Part 1 updates UPNG 2017 Tw @mdjkf http://idmic.net
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationAmoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate
Annex I List of the names, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, applicant in the Member States Member State EU/EEA Applicant Name
More informationMedical bacteriology Lecture 8. Streptococcal Diseases
Medical bacteriology Lecture 8 Streptococcal Diseases Streptococcus agalactiae Beat haemolytic Lancifield group B Regularly resides in human vagina, pharynx and large inine Can be transferred to infant
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationRESISTANCE, USE, INTERVENTIONS. Hugh Webb
RESISTANCE, USE, INTERVENTIONS Hugh Webb EU Initiatives: EARSS and ESAC. Antimicrobial Use and Resistance The Relationship. Bias and confounding in published studies. Mathematical modelling of resistance
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationand Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA
Journal of Antimicrobial Chemotherapy (2004) 54, Suppl. S1, i7 i15 DOI: 10.1093/jac/dkh313 JAC Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae
More informationPneumococci & streptococci Testing and clinical implications of susceptibility changes
Pneumococci & streptococci Testing and clinical implications of susceptibility changes Pierrette Melin Medical microbiology University Hospital of Liege,, Belgium pm-chu lg - May 2004 1 Key questions What
More information10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)
Beta-lactam antibiotics Penicillins Target - Cell wall - interfere with cross linking Actively growing cells Bind to Penicillin Binding Proteins Enzymes involved in cell wall synthesis Activity of an Antibiotic
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationAn#bio#cs and challenges in the wake of superbugs
An#bio#cs and challenges in the wake of superbugs www.biochemj.org/bj/330/0581/bj3300581.htm ciss.blog.olemiss.edu Dr. Vassie Ware Bioscience in the 21 st Century November 14, 2014 Who said this and what
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More informationReport on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"
Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding
More informationAntimicrobial use in poultry: Emerging public health problem
Antimicrobial use in poultry: Emerging public health problem Eric S. Mitema, BVM, MS, PhD CPD- Diagnosis and Treatment of Poultry Diseases FVM, CAVS, 6 th. August, 2014 AMR cont Antibiotics - Natural or
More informationInforming Public Policy on Agricultural Use of Antimicrobials in the United States: Strategies Developed by an NGO
Informing Public Policy on Agricultural Use of Antimicrobials in the United States: Strategies Developed by an NGO Stephen J. DeVincent, DVM, MA Director, Ecology Program Alliance for the Prudent Use of
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh
ANTIBIOTIC RESISTANCE Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationEUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins
EUAST Expert Rules for 2018 Organisms Agents tested Agents affected Rule aureus Oxacillin efoxitin (disk diffusion), detection of meca or mec gene or of PBP2a All β-lactams except those specifically licensed
More informationDANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme
DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationClindamycin coverage streptococcus
Clindamycin coverage streptococcus Oct 12, 2017. While clindamycin and erythromycin were at one time uniformly active against group B streptococci, resistance has been increasing. One large. We assessed
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationUPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS
UPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS OIE global Conference on the Responsible and Prudent use of Antimicrobial Agents for Animals Paris (France), 13
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationINTRODUCTION. Keywords Antimicrobial resistance, respiratory tract pathogens, surveillance principles and practice, global situation
Surveillance of resistance in bacteria causing community-acquired respiratory tract infections D. Felmingham 1, C. Feldman 2, W. Hryniewicz 3, K. Klugman 4,S.Kohno 5, D. E. Low 6, C. Mendes 7 and A. C.
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationIs erythromycin bactericidal
Is erythromycin bactericidal Search Comparison of erythromycin, clarithromycin, azithromycin, telithromycin, roxithromycin: mechanism of action, spectrum of activity, side effects, drug interactions. Erythromycin
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationMethicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationThe Threat of Multidrug Resistant Neisseria gonorrhoeae
The Threat of Multidrug Resistant Neisseria gonorrhoeae Peel Public Health Symposium Sex, Drugs, and. Vanessa Allen, MD MPH October 16, 2012 The threat of multidrug resistant gonorrhea "We're sitting on
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationRecommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee
VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD
More informationANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS
ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM025D March 2016 Neha Maliwal Project Analyst ISBN: 1-62296-252-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ
ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ Antibiotic resistance is rapidly emerging as a public health issue throughout the world. Mankind has enjoyed about half a century of virtual complete control
More informationAntibiotic Resistance in Spain: What Can Be Done?
819 INTERNATIONAL REPORT Antibiotic Resistance in Spain: What Can Be Done? Fernando Baquero and the Task Force of the General Direction for Health Planning of the Spanish Ministry of Health* From the Task
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationResponsible use of antimicrobials in veterinary practice
Responsible use of antimicrobials in veterinary practice Correct antimicrobial: as little as possible, as much as necessary This document provides more information to accompany our responsible use of antimicrobials
More informationAntibiotic use and pneumococcal resistance to penicillin: the French experience
Antibiotic use and pneumococcal resistance to penicillin: the French experience Clin Microbiol nfect 1999; 5: 4S3-4S42 Didier Guillemot ' and Claude Carbon 'nstitut National de la Sant6 et de la Recherche
More informationImpact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital
Impact of Antimicrobial Resistance on Human Health Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital AMR in Foodchain Conference, UCD, Dec 2014 Sir Patrick Dun s Hospital
More informationTREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationTreating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development
International Journal of Antimicrobial Agents 26 (2005) 62 68 Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development S. Simoens a,,
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationAntibiotic consumption and resistance selection in Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (2002) 50, Suppl. S2, 27 37 DOI: 10.1093/jac/dkf504 Antibiotic consumption and resistance selection in Streptococcus pneumoniae Fernando Baquero 1 *, Gregorio Baquero-Artigao
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationNeisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE
Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE Dra. Silvia E. González Ayala Head Professor Cátedra Infectología, Facultad Ciencias Médicas,
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationFrank Møller Aarestrup
Danish Veterinary Laboratory Bacterial populations and resistance development: Intestinal tract of meat animals Frank Møller Aarestrup 12 Antibiotic production 10 Mill. Kg 8 6 4 2 0 50 52 54 56 58 60 62
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More informationACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective
ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective Antwerpen 8 november 2002 Yvan Valcke MD PhD AZ Maria Middelares Sint-Niklaas ACUTE EXACERBATIONS of COPD (AE-COPD) Treatment of AECB Role
More informationAntimicrobial Stewardship in Ambulatory Care
Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationAntimicrobial Resistance Trends in the Province of British Columbia
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationAntibiotic Resistance in Bacteria
Antibiotic Resistance in Bacteria Electron Micrograph of E. Coli Diseases Caused by Bacteria 1928 1 2 Fleming 3 discovers penicillin the first antibiotic. Some Clinically Important Antibiotics Antibiotic
More informationWORKSHOP 6 Towards European consensus indications for major antibiotic classes: an exercise with the macrolides. Objectives
Objectives To establish the basic pharmacokinetic properties and safety profile of predefined macrolides. To make an inventory of the intrinsic susceptibilities of pathogenic organisms towards macrolides
More informationWhat is antimicrobial resistance?
What is antimicrobial resistance? Gérard MOULIN gerard.moulin@anses.fr French agency for food, environmental and occupationnal safety National agency for veterinary Medicinal Products BP 90203-35302 FOUGERES
More informationTitle: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More information